CHU Ste-Justine · Awarded contract
Awarded

Discovery of Novel Antibodies Against ETV6-RUNX1 Fusion Peptide-HLA Complex

Awarded 24 Feb 2025

View live tenders
Awarded24 Feb 2025
Value$210,319.41
ProvinceQuebec
CategoryResearch & Development
Ended 9mo ago1y term
Awarded 24 Feb 2025Expired 24 Feb 2026

CHU Ste-Justine awarded a contract to Immune Biosolutions inc.

for the discovery of new antibodies targeting the ETV6-RUNX1 fusion peptide-HLA complex, under the category of research and experimentation in medical sciences.

The contract was awarded through a negotiated (gré à gré) process, with a value of CAD 210,319.41.

Similar open tenders12

Long-term Illumina & PacBio Revio Sequencing Services for Human and Mouse DNA and RNA – Health Canada MSDResearch & Development
10 Dec 2026
On-Demand Contract for Capital Works and Medical Equipment Installation — HEJ, HSFA, HSS & Santé Québec HQ (CHU de Québec – Université Laval)Construction
01 Dec 2026
Oblitoxaximab Injection Procurement for Inhalation Anthrax – Public Health Agency of CanadaHealth & Medical
08 Dec 2026
HealthPRO RFP – Off‑Patent Hospital Injectable Pharmaceuticals (November 2026 Market Response)Health & Medical
15 Dec 2026
Acquisition of Automated Immunohistochemistry (IHC) Staining SystemHealth & Medical
24 Nov 2026
Supply of Two Benchtop Multiple Reactor Systems for NRC Clean Energy Innovation Research Centre (Canada)Research & Development
08 Dec 2026
Supply, Delivery and Installation of up to Two Real-Time PCR Instruments – Laboratory Services Branch, EtobicokeHealth & Medical
26 Nov 2026
Supply of Lab Centrifuges & Cytofuges (Free‑Standing and Tabletop) – Contract from 1 Jan 2027Health & Medical
23 Nov 2026
Acquisition of Automated Immunohematology Analyzers for Blood Bank – Medical Equipment SupplyHealth & Medical
01 Dec 2026
Automated Label-Free Biomolecular Interaction Analysis Platform (SPR or Equivalent)Research & Development
27 Nov 2026
Supply of Off‑Patent, Non‑Hospital General Trade Pharmaceuticals – November 2026 Market ResponseHealth & Medical
15 Dec 2026
Provincial Head, Complex Malignant Hematology — Ontario Health (Acute Leukemia, Stem Cell & CAR T Therapies)Health & Medical
03 Dec 2026

GovMarket

We do the hard work.
You win the work.

We find the tenders, read the documents and track who wins, so your time goes on bids you can win.

–open research and development tenders right now
–new in the last 7 days
–contracts awarded in the last 12 months
7 days free, then $59/CAD per month

You're In — Free Trial Activated

You now have full access to GovMarket Premium for 7 days. You’ll be charged at the end of the trial unless you cancel.

  • Tell Us What You Do — We'll surface the tenders that are most relevant to your business.